{
    "clinical_study": {
        "@rank": "89188", 
        "arm_group": [
            {
                "arm_group_label": "ovarian endometrioma", 
                "arm_group_type": "Experimental", 
                "description": "Ovarian and endometrial samples"
            }, 
            {
                "arm_group_label": "normal ovary", 
                "arm_group_type": "Experimental", 
                "description": "Ovarian and endometrial samples"
            }
        ], 
        "brief_summary": {
            "textblock": "Purpose of this study is to evaluate stem cell expression (SCE) in endometriotic (E) and non\n      endometriotic ovarian and endometrial tissues."
        }, 
        "brief_title": "Edessy Stem Cell Score (ESS), Endometrium, Endometrioma", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Endometriosis, Ovarian", 
        "condition_browse": {
            "mesh_term": "Endometriosis"
        }, 
        "detailed_description": {
            "textblock": "This study was conducted on 40 women at Al-Azhar University Hospitals. They are divided into\n      two equal groups, group 1 with ovarian endometrioma and group 2 with normal ovary. Ovarian\n      and endometrial samples were evaluated by hematoxlin & eosin for histopathology (HP) and of\n      oct-4 for immunohistochemistry (IH) for SCE.\n\n      Evaluation of IH parameters revealed that the most important factors for evaluating SC were\n      arranged as score ( Edessy Stem Cell Score=ESS)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20 to 40 years and did not receive hormonal treatment for three month\n\n        Exclusion Criteria:\n\n          -  Diabetes mellitus, cardiovascular and kidney diseases, adenomyosis, Uterine fibroid\n             Endometrial carcinoma  and Poly cystic ovary"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103452", 
            "org_study_id": "17819555"
        }, 
        "intervention": {
            "arm_group_label": [
                "ovarian endometrioma", 
                "normal ovary"
            ], 
            "description": "Ovarian and endometrial samples were evaluated by hematoxlin &amp;eosin for histopathology (HP) and of oct-4 for immunohistochemistry (IH) for SCE", 
            "intervention_name": "Ovarian and endometrial samples", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt"
                }, 
                "name": "Al Azhar University"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Edessy STEM CELL SCORE (ESS), Endometrium, Endometrioma", 
        "overall_official": [
            {
                "affiliation": "Al-Azhar University", 
                "last_name": "Mahmoud Edessy, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cairo University", 
                "last_name": "Hala hosni, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Al-Azhar University", 
                "last_name": "Magdy Olama, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Al-Azhar University", 
                "last_name": "Mohammad A Sattar, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Al-Azhar University", 
                "last_name": "Ahmad Monir, MSc", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Health and Population", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "ESS\nIntensity of stem cell marker:    Negative to mild =0,   Moderate =1,  Strong  =2\nPercentage of stained cells:  0 =0,   0-50%= 1,   >50-100% =2.\nFocality :  None =0,  Focal =1,   Diffuse= 2\nDistribution: None= 0, Epithelial or mesenchymal= 1, Epithelial and mesenchymal= 2.\nLocalization of positive stained cell: None=0, Cytoplasmic or nuclear =1, Cytoplasmic and nuclear= 2", 
            "measure": "Edessy Stem Cell Score (ESS)", 
            "safety_issue": "Yes", 
            "time_frame": "1 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103452"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Al-Azhar University", 
            "investigator_full_name": "Edessy Mahmoud", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Al-Azhar University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Al-Azhar University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}